CHINARES PHARMA (03320): KPC Pharmaceuticals, Inc. reported a net loss of 145 million yuan in the first quarter, a year-on-year profit turning into a loss.
China Resources Pharmaceutical Group (03320) released Kunyu Group's financial performance for the three months ending on March 31, 2026. The company achieved a total operating income of 836 million yuan, a decrease of 48.01% compared to the same period last year; with a net loss of 145 million yuan, compared to a profit of 114 million yuan in the same period last year.
CHINARES PHARMA (03320) released the financial performance of KPC Pharmaceuticals, Inc. for the three months ending March 31, 2026. The company achieved a total operating income of 836 million yuan, a year-on-year decrease of 48.01%; a net loss of 145 million yuan, compared to a profit of 114 million yuan in the same period last year.
Related Articles
On April 24th, AIRDOC-B (02251) spent 78,500 Hong Kong dollars to repurchase 6500 shares.
Cig Shanghai (06166): Directors and executives plan to reduce their holdings of company shares.
SHIYUE DAOTIAN(09676) Performance greatly increased in 2025 Strategic upgrade as "innovator of family food"
On April 24th, AIRDOC-B (02251) spent 78,500 Hong Kong dollars to repurchase 6500 shares.
Cig Shanghai (06166): Directors and executives plan to reduce their holdings of company shares.
SHIYUE DAOTIAN(09676) Performance greatly increased in 2025 Strategic upgrade as "innovator of family food"
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
